- Home
- BFRG vs IXHL Comparison
BFRG vs IXHL Comparison
Compare BFRG & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- IXHL
- Stock Information
- Founded
- BFRG 2017
- IXHL 2001
- Country
- BFRG United States
- IXHL Australia
- Employees
- BFRG N/A
- IXHL N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- IXHL
- Sector
- BFRG Technology
- IXHL
- Exchange
- BFRG Nasdaq
- IXHL Nasdaq
- Market Cap
- BFRG 14.8M
- IXHL 13.2M
- IPO Year
- BFRG 2023
- IXHL N/A
- Fundamental
- Price
- BFRG $1.42
- IXHL $0.63
- Analyst Decision
- BFRG
- IXHL
- Analyst Count
- BFRG 0
- IXHL 0
- Target Price
- BFRG N/A
- IXHL N/A
- AVG Volume (30 Days)
- BFRG 159.6K
- IXHL 61.4K
- Earning Date
- BFRG 05-09-2025
- IXHL 05-14-2025
- Dividend Yield
- BFRG N/A
- IXHL N/A
- EPS Growth
- BFRG N/A
- IXHL N/A
- EPS
- BFRG N/A
- IXHL N/A
- Revenue
- BFRG N/A
- IXHL $98,000.00
- Revenue This Year
- BFRG N/A
- IXHL $3,817.06
- Revenue Next Year
- BFRG N/A
- IXHL $66.67
- P/E Ratio
- BFRG N/A
- IXHL N/A
- Revenue Growth
- BFRG N/A
- IXHL N/A
- 52 Week Low
- BFRG $1.43
- IXHL $0.64
- 52 Week High
- BFRG $4.84
- IXHL $3.55
- Technical
- Relative Strength Index (RSI)
- BFRG 34.05
- IXHL 23.19
- Support Level
- BFRG $1.54
- IXHL $0.63
- Resistance Level
- BFRG $1.69
- IXHL $0.70
- Average True Range (ATR)
- BFRG 0.16
- IXHL 0.08
- MACD
- BFRG -0.00
- IXHL 0.02
- Stochastic Oscillator
- BFRG 7.69
- IXHL 2.93
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.